Calidi Biotherapeutics, Inc. Fair Value of Assets Acquired
Calidi Biotherapeutics, Inc. (CLDI) reported Fair Value of Assets Acquired of $11.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2025-03-31
- Calidi Biotherapeutics, Inc. fair value of assets acquired for the quarter ending 2024-12-31 was $0.00.
- Calidi Biotherapeutics, Inc. fair value of assets acquired for the quarter ending 2024-09-30 was -$9.00K.
- Calidi Biotherapeutics, Inc. fair value of assets acquired for the quarter ending 2024-06-30 was -$80.00K.
- Calidi Biotherapeutics, Inc. fair value of assets acquired for the quarter ending 2024-03-31 was $100.00K.
- Calidi Biotherapeutics, Inc. fair value of assets acquired for fiscal 2024 was $11.00K, a 94.50% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. fair value of assets acquired for fiscal 2023 was $200.00K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$9.00K derived: sum of 2 quarters · filed 2025-03-31 | -$89.00K derived: sum of 3 quarters · filed 2025-03-31 | $11.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$89.00K derived: sum of 2 quarters · filed 2024-11-12 | $11.00K 10-Q · filed 2024-11-12 | -$1.09M derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $20.00K 10-Q · filed 2024-08-13 | -$1.08M derived: sum of 3 quarters · filed 2025-03-31 | |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-14 | -$1.00M derived: sum of 2 quarters · filed 2025-03-31 | ||
| 2023-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $200.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |